Can we really use ß-lactam/ß-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ß-lactamase-producing bacteria?

Clin Infect Dis. 2012 Jan 15;54(2):175-7. doi: 10.1093/cid/cir793. Epub 2011 Nov 4.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Escherichia coli Infections / drug therapy*
  • Female
  • Humans
  • Male
  • Penicillanic Acid / analogs & derivatives*
  • Penicillanic Acid / therapeutic use
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination
  • beta-Lactamase Inhibitors*

Substances

  • Anti-Bacterial Agents
  • beta-Lactamase Inhibitors
  • Piperacillin, Tazobactam Drug Combination
  • Amoxicillin-Potassium Clavulanate Combination
  • Penicillanic Acid
  • Piperacillin